Note Agreements in the Pharmaceuticals Industry

1,656 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (3 contracts)
60 DEGREES PHARMACEUTICALS, INC. (29)
Acacia Diversified Holdings, Inc. (1)
Acasti Pharma Inc. (8)
Accelerated Pharma, Inc. (8)
Acer Therapeutics Inc. (12)
ACHILLION PHARMACEUTICALS INC (7)
Acreage Holdings, Inc. (1)
ACURA PHARMACEUTICALS, INC (20)
Adamis Pharmaceuticals Corp (17)
ADIAL PHARMACEUTICALS, INC. (9)
Aegerion Pharmaceuticals, Inc. (8)
AEOLUS PHARMACEUTICALS, INC. (5)
AEON Biopharma, Inc. (8)
AERIE PHARMACEUTICALS INC (2)
Aerpio Pharmaceuticals, Inc. (4)
AGILE THERAPEUTICS INC (1)
Akers Biosciences, Inc. (3)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (6)
Alexza Pharmaceuticals Inc. (8)
ALIMERA SCIENCES INC (1)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (28)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (2)
AmeriCann, Inc. (5)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (6)
AMYLIN PHARMACEUTICALS INC (6)
Angion Biomedica Corp. (3)
ANGIOTECH PHARMACEUTICALS INC (4)
ANI Pharma Inc (1)
Applied BioSciences Corp. (5)
APRICUS BIOSCIENCES, INC. (15)
Aquestive Therapeutics, Inc. (2)
ARADIGM CORP (6)
Aralez Pharmaceuticals Inc. (15)
ARIAD PHARMACEUTICALS INC (5)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (3)
Assertio Therapeutics, Inc (7)
Astex Pharmaceuticals, Inc (3)
AUXILIUM PHARMACEUTICALS INC (1)
AVALON PHARMACEUTICALS INC (3)
AVENUE THERAPEUTICS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (13)
AYTU BIOSCIENCE, INC (6)
Bakhu Holdings, Corp. (2)
Barrel Energy Inc. (2)
Baudax Bio, Inc. (1)
Bespoke Extracts, Inc. (4)
Big Rock Partners Acquisition Corp. (11)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
BioPharmX Corp (6)
Blue Water Acquisition Corp. (2)
BODY & MIND INC. (4)
Bohai Pharmaceuticals Group, Inc. (6)
Boston Therapeutics, Inc. (13)
Bristol-Myers Squibb (13)
Canbiola, Inc. (30)
Cancer Prevention Pharmaceuticals, Inc. (7)
Cannabics Pharmaceuticals Inc. (6)
CANNAPHARMARX, INC. (2)
CANNAPOWDER, INC. (6)
Canopy Growth Corp (1)
CARDAX, INC. (6)
Celexus, Inc (4)
CELGENE CORP (20)
Cerecor Inc. (2)
Charlotte's Web Holdings, Inc. (1)
CHINA PHARMA HOLDINGS, INC. (2)
Cingulate Inc. (11)
Citius Pharmaceuticals, Inc. (6)
Clever Leaves Holdings Inc. (3)
CLS Holdings USA, Inc. (45)
Cocrystal Pharma, Inc. (9)
COLLEGIUM PHARMACEUTICAL, INC (2)
ContraVir Pharmaceuticals, Inc. (2)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (4)
COSMO VENTURES INC (23)
CUBIST PHARMACEUTICALS INC (2)
Cure Pharmaceutical Holding Corp. (12)
Dova Pharmaceuticals Inc. (1)
Egalet Corp (1)
ELITE PHARMACEUTICALS INC (3)
Eloxx Pharmaceuticals, Inc. (5)
Endexx Corp (7)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (2)
EPIX Pharmaceuticals, Inc. (3)
Eton Pharmaceuticals, Inc. (2)
Evofem Biosciences, Inc. (14)
Evolus, Inc. (3)
Exactus, Inc. (11)
EYENOVIA, INC. (1)
FERMAVIR PHARMACEUTICALS, INC. (2)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (28)
GENAISSANCE PHARMACEUTICALS INC (1)
GREEN HYGIENICS HOLDINGS INC. (5)
Green Thumb Industries Inc. (2)
GridIron BioNutrients, Inc. (11)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (4)
Haymaker Acquisition Corp. III (1)
HERATSI PHARMACEUTICALS (2)
Horizon Pharma plc (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
IMAGING3 INC (19)
INNOVATE BIOPHARMACEUTICALS, INC. (10)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (6)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (1)
Jaguar Health, Inc. (27)
Jazz Pharmaceuticals plc (3)
Jiangbo Pharmaceuticals, Inc. (1)
Johnson & Johnson (5)
Journey Medical Corp (1)
JUNIPER PHARMACEUTICALS INC (3)
Jushi Holdings Inc. (1)
Kannalife Inc (5)
Kaya Holdings, Inc. (5)
Kedem Pharmaceuticals Inc. (4)
KEMPHARM, INC (6)
KID CASTLE EDUCATIONAL CORP (2)
Level Brands, Inc. (5)
Lilly (Eli) & Co. (18)
LIPELLA PHARMACEUTICALS INC (3)
Lotus Pharmaceuticals, Inc. (1)
Luckwel Pharmaceuticals Inc. (1)
Mallinckrodt (9)
Marijuana Co of America, Inc. (3)
MedGen, Inc. (6)
Medicine Man Technologies, Inc. (8)
MedMen Enterprises, Inc. (3)
Merck (45)
MICROCHANNEL TECHNOLOGIES CORP (25)
Milestone Pharmaceuticals Inc. (2)
MJ BIOTECH, INC. (3)
MJ Holdings, Inc. (10)
Mylan N.V. (3)
MYnd Analytics, Inc. (64)
NAREK PHARMACEUTICALS (2)
NEKTAR THERAPEUTICS (5)
Neos Therapeutics, Inc. (7)
Neuralstem, Inc. (1)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (10)
NEXIEN BIOPHARMA, INC. (7)
Notis Global, Inc. (23)
NovaBay Pharmaceuticals, Inc. (11)
Novan, Inc. (2)
NPS PHARMACEUTICALS INC (1)
OCULAR THERAPEUTIX, INC (2)
OMEROS CORP (10)
Omthera Pharmaceuticals, Inc. (1)
One World Pharma, Inc. (14)
ONYX PHARMACEUTICALS INC (2)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (2)
ORAMED PHARMACEUTICALS INC. (1)
OSCIENT PHARMACEUTICALS CORP (2)
Osmotica Pharmaceuticals plc (3)
Pacira Pharmaceuticals, Inc. (1)
Panacea Acquisition Corp (3)
Paratek Pharmaceuticals, Inc. (1)
PaxMedica, Inc. (7)
PEAK PHARMACEUTICALS, INC. (21)
Perrigo (4)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (2)
Pfizer (3)
Pharmagreen Biotech Inc. (4)
Phathom Pharmaceuticals, Inc. (2)
Phoenix Life Sciences International Limited. (1)
PLAYERS NETWORK (37)
PONIARD PHARMACEUTICALS, INC. (2)
Prestige Brands Holdings Inc (1)
Processa Pharmaceuticals, Inc. (4)
ProPhase Labs, Inc. (6)
PROVECTUS BIOPHARMACEUTICALS, INC. (13)
QUANTA INC (4)
RADIENT PHARMACEUTICALS Corp (10)
Rani Therapeutics Holdings, Inc. (1)
Recro Pharma, Inc. (3)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (27)
Revance Therapeutics, Inc. (1)
Rib-X Pharmaceuticals, Inc. (11)
ROCK CREEK PHARMACEUTICALS, INC. (3)
SALIX PHARMACEUTICALS LTD (6)
SCYNEXIS INC (3)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
SIGA TECHNOLOGIES INC (4)
Sucampo Pharmaceuticals, Inc. (3)
Sunset Island Group (5)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (2)
Synovics Pharmaceuticals (2)
TAPESTRY PHARMACEUTICALS, INC (1)
Target Group Inc. (5)
Targeted Medical Pharma, Inc. (1)
TAURIGA SCIENCES, INC. (76)
Tenzing Acquisition Corp. (8)
Terra Tech Corp. (54)
TETRALOGIC PHARMACEUTICALS CORP (6)
TETRAPHASE PHARMACEUTICALS INC (1)
Textmunication Holdings, Inc. (29)
THAR PHARMACEUTICALS INC (2)
TherapeuticsMD, Inc. (28)
Theravance Biopharma, Inc. (2)
Thomas Pharmaceuticals, Ltd. (2)
Tilray, Inc. (11)
TILT Holdings Inc. (13)
TITAN PHARMACEUTICALS INC (3)
Tribute Pharmaceuticals Canada Inc. (7)
Trulieve Cannabis Corp. (2)
United Cannabis Corp (6)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (6)
Vallon Pharmaceuticals, Inc. (5)
VASO ACTIVE PHARMACEUTICALS INC (1)
Verano Holdings Corp. (1)
VERBENA PHARMACEUTICALS INC (2)
VIA Pharmaceuticals, Inc. (10)
VION PHARMACEUTICALS INC (1)
VioQuest Pharmaceuticals, Inc. (3)
Vireo Health International, Inc. (1)
Virpax Pharmaceuticals, Inc. (15)
Vitality Biopharma, Inc. (3)
VIVUS INC (3)
WEED, INC. (2)
XERIS PHARMACEUTICALS INC (1)
Zoetis (4)
ZOGENIX, INC. (1)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Demand Promissory Note dated April 10, 2024 (RespireRx Pharmaceuticals Inc., Filed With SEC on April 16, 2024)
Amendment No. 1 to Convertible Promissory Note Purchase Agreement, by and among the Company, Navy Capital Green Fund, LP, Navy Capital Green Co- Invest Fund, LLC and HI 4Front, LLC (4Front Ventures Corp., Filed With SEC on April 15, 2024)
Promissory Note dated February 29, 2024 issued by Can B Corp. to ClearThink Capital Partners, LLC (Canbiola, Inc., Filed With SEC on April 15, 2024)
Promissory Note dated December 20, 2023 issued by Can B Corp. to ClearThink Capital Partners, LLC (Canbiola, Inc., Filed With SEC on April 15, 2024)
Promissory Note dated September 22, 2023 issued by Can B Corp. to ClearThink Capital Partners, LLC (Canbiola, Inc., Filed With SEC on April 15, 2024)
Amendment Modification to Convertible Promissory Note dated August 7, 2023 between Can B Corp. and ClearThink Capital Partners, LLC (Canbiola, Inc., Filed With SEC on April 15, 2024)
Promissory note in the amount of $26,134,500 payable by 1945689 Ontario Limited (Tilray, Inc., Filed With SEC on April 9, 2024)
Ex. 10.14 to 10-K__Form of Amendment No. 1 to Promissory Note dated March 5, 2024 by and between the Issuer and FirstFire Global Opportunities Fund LLC (Exactus, Inc., Filed With SEC on April 1, 2024)
Third Amendment to the Senior Secured Bridge Notes between iAnthus New Jersey, LLC and the holders hereto dated February 16, 2024 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on March 28, 2024)
Amendment No. 5 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective March 27, 2024 (APRICUS BIOSCIENCES, INC., Filed With SEC on March 28, 2024)
Form of Unsecured Convertible Notes (NovaBay Pharmaceuticals, Inc., Filed With SEC on March 25, 2024)
Form of Version 3 Note dated March 15, 2024 (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on March 21, 2024)
Form of Version 2 Note dated March 15, 2024 (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on March 21, 2024)
Form of Version 1 Note dated March 15, 2024 (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on March 21, 2024)
Form of Convertible Note Purchase Agreement dated March 15, 2024 (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on March 21, 2024)
First Amendment and Waiver to the Note Purchase Agreement (OptiNose, Inc., Filed With SEC on March 7, 2024)
Form of Convertible Secured Promissory Note (Bakhu Holdings, Corp., Filed With SEC on March 5, 2024)
Form of Convertible Promissory Note Due February 24, 2025 (MYnd Analytics, Inc., Filed With SEC on February 26, 2024)
Secured Promissory Note dated February 22, 2024, made by the Company in favor of Ian Whitmore (CLS Holdings USA, Inc., Filed With SEC on February 26, 2024)
Secured Promissory Note dated February 22, 2024, made by the Company in favor of LEM Investments LLC (CLS Holdings USA, Inc., Filed With SEC on February 26, 2024)
Secured Promissory Note dated February 22, 2024, made by the Company in favor of Patrick Haldan (CLS Holdings USA, Inc., Filed With SEC on February 26, 2024)
Secured Promissory Note dated February 22, 2024, made by the Company in favor of FK Legacy Trust (CLS Holdings USA, Inc., Filed With SEC on February 26, 2024)
Convertible Promissory Note dated February 14, 2024 issued to Quick Capital, LLC (NEXIEN BIOPHARMA, INC., Filed With SEC on February 20, 2024)
Note Purchase Agreement dated February 14, 2024 between the Company and Quick Capital, LLC (NEXIEN BIOPHARMA, INC., Filed With SEC on February 20, 2024)
Form of Note (Bespoke Extracts, Inc., Filed With SEC on February 20, 2024)
Amendment #3 to Convertible Promissory Note, dated February 9, 2024, by and between NRx Pharmaceuticals, Inc. and Streetervillle Capital LLC (Big Rock Partners Acquisition Corp., Filed With SEC on February 14, 2024)
Form of Officers Certificate setting forth the terms and form of the Notes (Lilly (Eli) & Co., Filed With SEC on February 9, 2024)
Amended and Restated Convertible Note due January 30, 2025 in the amount of $54,000 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (RespireRx Pharmaceuticals Inc., Filed With SEC on February 2, 2024)
Amended and Restated Convertible Note due January 30, 2025 in the amount of $40,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (RespireRx Pharmaceuticals Inc., Filed With SEC on February 2, 2024)
Amended and Restated Convertible Note due January 30, 2025 in the amount of $85,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (RespireRx Pharmaceuticals Inc., Filed With SEC on February 2, 2024)
Convertible Promissory Note dated January 30, 2024 (Level Brands, Inc., Filed With SEC on February 2, 2024)
Note Conversion Agreement, dated January 25, 2024, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Cingulate Inc., Filed With SEC on January 29, 2024)
Form of Secured Promissory Note (CLS Holdings USA, Inc., Filed With SEC on January 9, 2024)
Promissory Note, dated as of December 26, 2023, by Borrower, in favor of First Federal Bank (Verano Holdings Corp., Filed With SEC on January 2, 2024)
EXHIBIT A FORM OF NOTE (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on December 28, 2023)
CONVERTIBLE NOTE PURCHASE AGREEMENT (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on December 28, 2023)
Form of Original Issue Discount Secured Convertible Promissory Note (GridIron BioNutrients, Inc., Filed With SEC on December 13, 2023)
Form of Senior Subordinated Convertible Note (Evofem Biosciences, Inc., Filed With SEC on December 7, 2023)
Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau (TITAN PHARMACEUTICALS INC, Filed With SEC on November 14, 2023)
Promissory Note dated September 28, 2023 (MYnd Analytics, Inc., Filed With SEC on November 14, 2023)